Public Sector Pension Investment Board Zai Lab LTD Transaction History

Public Sector Pension Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$30.21 - $48.1 $12,084 - $19,240	-400 Reduced 1.29%	30,707 $1.02 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $13,368 - $23,226	-600 Reduced 1.89%	31,107 $954,000
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $17,100 - $25,845	500 Added 1.6%	31,707 $1.08 Million
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $90,246 - $193,752	3,900 Added 14.28%	31,207 $1.08 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $1.5 Million - $2.87 Million	27,307 New	27,307 $1.72 Million

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.